NCT02419677已完成2 期
Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Recurrence-free survival
研究概览
简要总结
The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with colorectal cancer liver metastases (CRCLM).
详细描述
The primary objective is to evaluate whether RFA followed by CIK transfusion can prolong survival of patients with resectable CRCLM.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with histologically confirmed adenocarcinoma
- •Primary lesions (colorectal cancer) are resected
- •Must have undergone prior complete resection of the primary tumor; liver metastases
- •Must be resectable or accessible for radiofrequency ablation (Five or less lung metastases measuring 5 cm or smaller).
- •Serum bilirubin level of 2.0 mg/dl or less.
- •Performance status of 0 or
- •Expected survival of 1 year or more.
- •Informed consent from the patient.
排除标准
- •With extrahepatic metastases
- •With other neoplastic disease that is measurable or being treated other than colorectal cancer.
结局指标
主要结局
Recurrence-free survival
时间窗: One year
Recurrence-free survival (RFS) was defined as the time from the date of RFA to the date of recurrence or the date of the last follow-up.
次要结局
- Adverse events(4 weeks)
研究者
Liangrong Shi
Director of Science and Education Division
The First People's Hospital of Changzhou
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical CancerCervical CancerNCT02490748The First People's Hospital of Changzhou10
进行中（未招募）
2 期
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With CholangiocarcinomaCholangiocarcinomaNCT02482454The First People's Hospital of Changzhou50
进行中（未招募）
2 期
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian CarcinomaOvarian CarcinomaNCT02487693The First People's Hospital of Changzhou50
Unknown
4 期
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular CarcinomaLiver CancerHepatocellular CarcinomaNCT00554905Sun Yat-sen University180
撤回
4 期
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver MetastasesMetastatic Liver CancerSecondary Liver CancerLiver NeoplasmNCT00510627Boston Scientific Corporation